Between hype and hope: Seattle biotech leaders size up AI’s real impact on drug development Seattle biotech companies are using AI to design new medical treatments, but scientists caution the tech holds enormous promise, but needs to stay grounded in reality. Read More
GeekWire Awards: Health Innovation of the Year field is dominated by finalists battling cancer The GeekWire Awards finalists for Health Innovation of the Year are dominated by ventures that aim to outwit cancer with… Read More
Archon Biosciences emerges from stealth with $20M to create tiny ‘Antibody Cages’ Three weeks after University of Washington biochemist David Baker won a Nobel Prize, the latest venture to spin out from… Read More
